全文获取类型
收费全文 | 16284篇 |
免费 | 1420篇 |
国内免费 | 1423篇 |
专业分类
19127篇 |
出版年
2024年 | 53篇 |
2023年 | 252篇 |
2022年 | 498篇 |
2021年 | 810篇 |
2020年 | 671篇 |
2019年 | 748篇 |
2018年 | 730篇 |
2017年 | 529篇 |
2016年 | 711篇 |
2015年 | 1063篇 |
2014年 | 1270篇 |
2013年 | 1300篇 |
2012年 | 1501篇 |
2011年 | 1342篇 |
2010年 | 920篇 |
2009年 | 748篇 |
2008年 | 802篇 |
2007年 | 722篇 |
2006年 | 704篇 |
2005年 | 573篇 |
2004年 | 495篇 |
2003年 | 522篇 |
2002年 | 412篇 |
2001年 | 245篇 |
2000年 | 221篇 |
1999年 | 212篇 |
1998年 | 142篇 |
1997年 | 118篇 |
1996年 | 119篇 |
1995年 | 116篇 |
1994年 | 99篇 |
1993年 | 61篇 |
1992年 | 80篇 |
1991年 | 67篇 |
1990年 | 62篇 |
1989年 | 44篇 |
1988年 | 29篇 |
1987年 | 24篇 |
1986年 | 36篇 |
1985年 | 25篇 |
1984年 | 14篇 |
1983年 | 8篇 |
1982年 | 8篇 |
1981年 | 5篇 |
1980年 | 3篇 |
1979年 | 3篇 |
1976年 | 2篇 |
1970年 | 1篇 |
1962年 | 2篇 |
1950年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
[目的]研究中度嗜盐菌Martelella sp.AD-3在降解菲过程中水杨酸-5-羟化酶的活性与菲降解效率的关系及其酶学性质.[方法]通过HPLC分析菲的降解效率和AD-3菌粗酶液催化水杨酸的产物,根据NADH在340 nm处的吸光度变化计算水杨酸-5-羟化酶的活性.[结果]水杨酸-5-羟化酶是一种诱导酶,在AD-3菌的对数生长期和稳定初期时活性较高,酶活力大小与该菌对菲的降解速率基本一致.在菲浓度为200 mg/L、生长盐度为3%、pH为9.0的培养条件下,AD-3菌株表达的水杨酸-5-羟化酶的活力最高,为132.8 nmol/(min·mg).水杨酸-5-羟化酶催化水杨酸降解时的最适温度、pH和盐度分别为30℃、7.5和3%,酶的最大反应速率为200 nmol/(min· mg)、米氏常数Km为8.7μmol/L.[结论]AD-3菌在降解菲的过程中表达水杨酸-5-羟化酶,该酶的活性与菲降解速率具有相关性. 相似文献
92.
Díaz-Valencia JD Morelli MM Bailey M Zhang D Sharp DJ Ross JL 《Biophysical journal》2011,100(10):2440-2449
Microtubule (MT) length and location is tightly controlled in cells. One novel family of MT-associated proteins that regulates MT dynamics is the MT-severing enzymes. In this work, we investigate how katanin (p60), believed to be the first discovered severing enzyme, binds and severs MTs via single molecule total internal reflection fluorescence microscopy. We find that severing activity depends on katanin concentration. We also find that katanin can remove tubulin dimers from the ends of MTs, appearing to depolymerize MTs. Strikingly, katanin localizes and severs at the interface of GMPCPP-tubulin and GDP-tubulin suggesting that it targets to protofilament-shift defects. Finally, we observe that binding duration, mobility, and oligomerization are ATP dependent. 相似文献
93.
Lizcano JM Deak M Morrice N Kieloch A Hastie CJ Dong L Schutkowski M Reimer U Alessi DR 《The Journal of biological chemistry》2002,277(31):27839-27849
94.
95.
本文是对出土于新疆哈密地区天山北路青铜时代墓地颅骨测量性状的研究。文中公布了24例天山北路墓地古代人群77项颅骨测量性状基本数据, 在此基础上, 对男、女两性的测量性状特点进行了统计分析, 并结合考古学文化研究和分子生物学研究的相关结论对实验结果进行了讨论和推论。主要研究结论如下: 一是该人群虽已经形成了具有自身特点的、共性的体质特征, 但人群内部也存在些许差异, 尤其是在男性个体数据之中。二是该人群是由分别具有东、西方体质特征的祖先人群混杂融合而成, 是处于当时大人种分布过渡地带的过渡人群。 相似文献
96.
97.
Han YW Aleyas AG George JA Kim SJ Kim HK Yoo DJ Kang SH Eo SK 《Immunology and cell biology》2009,87(1):91-99
The CC chemokine receptor 7 (CCR7) and cognate CCR7 ligands, CCL19 and CCL21, help establish microenvironments in lymphoid tissue that can facilitate encounters between naive T cells and mature dendritic cells (DCs). This study was conducted to determine if CCR7 ligands can augment the immunogenicity of a DNA vaccine that expresses glycoprotein B (gB) of the pseudorabies virus (PrV). The genetic co-transfer of CCR7 ligands along with a PrV DNA vaccine increased the levels of serum PrV-specific immunoglobulin (Ig) G by 2- to 2.5-fold. In addition, the level of PrV-specific IgG2a isotype was significantly enhanced by co-injection of CCR7 ligand DNA, which indicates that CCR7 ligand biases the humoral immunity toward the Th1-type pattern. The co-injection of CCR7 ligand DNA consistently enhanced the level of Th1-type cytokines (IL-2 and IFN-gamma) produced by stimulated immune cells when compared with a group that was vaccinated with the PrV DNA vaccine. Also, the genetic co-transfer of CCR7 ligand DNAs with PrV DNA vaccine provided prolonged survival against a virulent challenge by PrV. Moreover, the co-administration of CCR7 ligand DNA increased the number of mature DCs into the secondary lymphoid tissues, which appeared to enhance the proliferation of PrV-immune CD4(+) T cells. Taken together, these findings indicate that CCR7 ligands are an attractive adjuvant for a PrV DNA vaccine that can offer protective immunity against the PrV. 相似文献
98.
Hye Ran Park Jae Meen Lee Gwanhee Ehm Hui-Jun Yang In Ho Song Yong Hoon Lim Mi-Ryoung Kim Keyoung Ran Kim Woong-Woo Lee Young Eun Kim Jae Ha Hwang Chae Won Shin Hyeyoung Park Jin Wook Kim Han-Joon Kim Cheolyoung Kim Dong Gyu Kim Beom Seok Jeon Sun Ha Paek 《PloS one》2016,11(1)
Background
GPi (Internal globus pallidus) DBS (deep brain stimulation) is recognized as a safe, reliable, reversible and adjustable treatment in patients with medically refractory dystonia.Objectives
This report describes the long-term clinical outcome of 36 patients implanted with GPi DBS at the Neurosurgery Department of Seoul National University Hospital.Methods
Nine patients with a known genetic cause, 12 patients with acquired dystonia, and 15 patients with isolated dystonia without a known genetic cause were included. When categorized by phenomenology, 29 patients had generalized, 5 patients had segmental, and 2 patients had multifocal dystonia. Patients were assessed preoperatively and at defined follow-up examinations postoperatively, using the Burke-Fahn-Marsden dystonia rating scale (BFMDRS) for movement and functional disability assessment. The mean follow-up duration was 47 months (range, 12–84)Results
The mean movement scores significantly decreased from 44.88 points preoperatively to 26.45 points at 60-month follow up (N = 19, P = 0.006). The mean disability score was also decreased over time, from 11.54 points preoperatively to 8.26 points at 60-month follow up, despite no statistical significance (N = 19, P = 0.073). When analyzed the movement and disability improvement rates at 12-month follow up point, no significant difference was noted according to etiology, disease duration, age at surgery, age of onset, and phenomenology. However, the patients with DYT-1 dystonia and isolated dystonia without a known genetic cause showed marked improvement.Conclusions
GPi DBS is a safe and efficient therapeutic method for treatment of dystonia patients to improve both movement and disability. However, this study has some limitations caused by the retrospective design with small sample size in a single-center. 相似文献99.
为了研究家蚕 Bombyx mori 溶茧酶基因 (cocoonae)真核表达及其产物的生物活性,将溶茧酶基因(GenBank 登录号 EF428980)克隆至杆状病毒转移载体 pFastBacTM 1 中获得 pFast-cocoonase,将其转化 DH10Bac 感受态细胞后,PCR 方法检测证实所分离的重组病毒 DNA 中含有目的片段溶茧酶基因。用脂质体法 转染家蚕 BmN 细胞,获得重组病毒。SDS-PAGE 分析显示,感染重组杆状病毒 Bac-cocoonase 的细胞表达产物在约为 27.6 kD 处出现特异性条带,这与预测的蛋白大小相符。用该表达产物与茧丝反应后,电镜下观察茧丝的形态,结果表明表达产物对茧丝的丝胶层有一定的水解作用。 相似文献
100.
Zhenfeng Zhang Mohan Zhao Yuanyuan Chen Li Wang Qinghua Liu Yuhui Dong Yong Gong Li Huang 《Molecular microbiology》2019,111(3):556-569
Archaea have evolved various strategies in chromosomal organization. While histone homologues exist in most archaeal phyla, Cren7 is a chromatin protein conserved in the Crenarchaeota. Here, we show that Cren7 preferentially binds DNA with AT‐rich sequences over that with GC‐rich sequences with a binding size of 6~7 bp. Structural studies of Cren7 in complex with either an 18‐bp or a 20‐bp double‐stranded DNA fragment reveal that Cren7 binds to the minor groove of DNA as monomers in a head‐to‐tail manner. The neighboring Cren7 monomers are located on the opposite sides of the DNA duplex, with each introducing a single‐step sharp kink by intercalation of the hydrophobic side chain of Leu28, bending the DNA into an S‐shape conformation. A structural model for the chromatin fiber folded by Cren7 was established and verified by the analysis of cross‐linked Cren7‐DNA complexes by atomic force microscopy. Our results suggest that Cren7 differs significantly from Sul7, another chromatin protein conserved among Sulfolobus species, in both DNA binding and deformation. These data shed significant light on the strategy of chromosomal DNA organization in crenarchaea. 相似文献